CBD product liability issues – taking proactive steps to mitigate risk
As the legal landscape for hemp continues to evolve, manufacturers and sellers of CBD products face increased challenges, such as an...
Life Sciences
Contributors
-
Solicitor -
-
Of Counsel -
Partner -
Senior Associate -
-
-
-
Partner -
Senior Associate (Rechtsanwalt) -
Corporate Associate -
Senior Associate -
-
-
Special Counsel -
Marketing & Business Development Manager
-
Partner -
-
-
-
-
Marketing Coordinator, International Practice Groups & Sectors
-
Partner -
Partner -
Global Co-Chair Life Science Partner -
Senior Marketing Manager -
-
-
-
Lawyer -
-
-
Senior Associate -
Partner, Healthcare Industry Sector -
Partner -
-
Partner -
Associate
-
-
-
-
-
Associate
-
Senior Associate -
Partner, Head of Patents
DLA Piper Life Sciences Archive
- November 2020 (6)
- October 2020 (5)
- September 2020 (4)
- July 2020 (2)
- June 2020 (1)
- May 2020 (2)
- April 2020 (6)
- March 2020 (1)
- February 2020 (2)
- January 2020 (4)
- November 2019 (2)
- October 2019 (1)
- August 2019 (1)
- July 2019 (5)
- May 2019 (6)
- March 2019 (2)
- February 2019 (4)
- January 2019 (1)
- December 2018 (2)
- November 2018 (2)
- October 2018 (1)
- August 2018 (1)
- July 2018 (2)
- May 2018 (1)
- April 2018 (3)
- March 2018 (8)
- February 2018 (1)
- December 2017 (5)
- November 2017 (15)
- October 2017 (7)
Telehealth around the world: A global guide
The COVID-19 pandemic has caused healthcare systems around the globe to rapidly, and in some cases, radically rethink the delivery of...
Kanavape: a victory for CBD producers across Europe
The Court of Justice of the European Union (CJEU) has ruled that EU Member States cannot prohibit the marketing of cannabidiol (CBD)...
New Zealand referendum for the legalisation of recreational cannabis fails
By a slim majority of 50.7% to 48.4%, New Zealanders have voted against the legalisation of recreational cannabis following the...
The US Hemp Production Handbook
Hemp production in the US has soared in the last five years and is expected to continue its high rate of production and growth in the...
CBD as a novel food: the UK's stance post-Brexit
The UK FSA's announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net